Advertisement
Advertisement

IRIX

IRIX logo

Iridex Corp

1.16
USD
-0.06
-4.92%
Apr 24, 15:24 UTC -4
Open

Iridex Corp Profile

About

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Info & Links

CEO

Patrick Mercer

Headquarters

1212 Terra Bella Avenue
Mountain View, CA 94043, UNITED STATES

Auditor

BPM LLP

Share holders

33

Employees

93

Iridex Corp Statistics

Valuation Measures

Market Capitalization2

19.30M

Enterprise Value

19.65M

Enterprise Value/EBITDA(ttm)

-2.61

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.52

Price to Book(mrq)

9.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

39.97%

Operating Margin(ttm)

-22.79%

Profit Margin(ttm)

-18.48%

Return on Equity(ttm)

-192.95%

Return on Invested Capital(ttm)

-190.91%

Return on Assets(ttm)

-33.97%

Income Statement

Revenue(ttm)

48.67M

Revenue Per Share(ttm)

2.90

Gross Profit(ttm)

19.50M

EBITDA(ttm)3

-7.54M

Net Income Available to Common(ttm)

-8.91M

Diluted EPS(ttm)

-0.67

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

-61.72%

S&P 500 52-Week Change

7.76%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

16.79M

Dividend Yield

0.00%

Float4

15.42M

% Held by Insiders

7.30%

% Held by Institutions

20.10%

Balance Sheet

Total Cash(mrq)

2.39M

Total Cash Per Share(mrq)

0.14

Total Debt(mrq)

2.74M

Total Debt/Equity(mrq)

130.57%

Current Ratio(mrq)

1.42%

Quick Ratio(mrq)

0.85%

Book Value Per Share(mrq)

0.13

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.44

Free Cash Flow(ytd)

-7.30M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement